文献速递临床试验与 GCP

可控局部气囊加压胸带预防乳腺癌术后血清肿:遵义随机对照试验方案

Controlled local air-balloon compression chest belt on postoperative seroma in breast cancer: study protocol for a randomised controlled trial in Zunyi, China.
PubMed 文献 · Trials · 2026-06-24

主要结局为血清肿发生率、术后引流量和引流管留置时间,旨在比较两种加压方式预防术后血清肿的疗效。

要点

  • 可控局部气囊加压胸带通过压力传感器测量气囊充气水平,充气值范围为4至8 kPa。
  • 两组胸带均佩戴一个月,气囊充气期持续一周。
  • 主要结局包括血清肿发生率、术后引流量和引流管留置时间。

核心结论

  • 旨在比较标准弹性胸带与可控局部气囊加压胸带预防乳腺癌术后血清肿的疗效。

关键数值与推荐

  • 纳入标准为年龄18岁及以上、诊断为单侧乳腺癌、符合乳房切除术(包括改良根治术和/或单纯乳房切除术)指征并签署知情同意书。
  • 排除标准包括术前严重合并症、胸部畸形或创伤、胸带过敏以及无法配合的精神疾病患者。
  • 干预组使用可控压力局部气囊胸带,气囊充气值范围为4至8 kPa,充气期一周,两组胸带均佩戴一个月。
  • 主要结局为血清肿发生率、术后引流量和引流管留置时间,次要结局包括生活质量、舒适度和胸带满意度。

临床怎么用

  • 术后伤口加压敷料有助于促进皮瓣与胸壁贴合并减少腔隙,从而预防血清肿形成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Seroma formation is a common postoperative complication of breast cancer surgery, leading to delayed wound healing, infection, patient discomfort, and repeated outpatient visits. In severe cases, it can cause skin flap necrosis, imposing physical, psychological, and financial burdens on patients. Applying compression bandaging to the patient's postoperative wound with a chest strap is an effective measure to prevent seroma formation. However, the commonly used elastic chest straps cannot provide specific compression values, limiting their use. Therefore, we aim to compare the efficacy of standard elastic chest straps versus controlled localised air-balloon compression chest straps in preventing seroma formation following breast cancer surgery. METHODS: This is a superiority, single-blind randomised controlled trial conducted at a tertiary hospital in Guizhou Province, China, involving female breast cancer patients undergoing mastectomy. Eligible participants will be recruited by attending surgeons during routine preoperative consultations. Patients aged 18 years or older diagnosed with unilateral breast cancer who meet the criteria for mastectomy (including modified radical mastectomy and/or simple mastectomy) and provide informed consent will be eligible for inclusion. Exclusion criteria include patients with severe concomitant diseases before surgery, those with chest deformities or trauma, those with chest strap allergies, and those with psychiatric disorders who are unable to cooperate. Sixty patients were randomly assigned to two groups (control group and intervention group) in a 1:1 ratio, without stratification. Patients in the control group received postoperative compression bandaging with standard elastic chest bandages. In contrast, those in the intervention group received postoperative compression bandaging with a controlled-pressure local air-balloon chest bandage, with pressure sensors measuring the air-balloon inflation level. The air-balloon inflation period lasted one week, with inflation values ranging from 4 to 8 kPa. Both sets of chest straps were worn for one month. Safety measures to be collected include adverse events, postoperative complications (seroma, wound infection), and device-related skin reactions or discomfort. Primary outcomes included seroma incidence, postoperative drainage volume, and drainage tube retention time. Secondary outcomes encompassed quality of life, comfort, and satisfaction with the chest straps. DISCUSSION: Postoperative wound compression dressing is essential for promoting flap-to-chest wall adhesion, reducing cavities, preventing seroma formation, and facilitating wound healing. By applying the Controlled Local Air-Balloon Compression Chest Belt, we aim to reduce postoperative complications, improve postoperative comfort, and promote patient recovery. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR), ChiCTR 2500105194. Date of first planned enrolment: February 2025. June 30, 2025 (Clinical Trial Registration Date, retrospectively registered). https://www.chictr.org.cn/showproj.html?proj=277304.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yang Y, Yang L, Zhang N, et al. Controlled local air-balloon compression chest belt on postoperative seroma in breast cancer: study protocol for a randomised controlled trial in Zunyi, China. Trials. 2026. PMID: 42343403. doi:10.1186/s13063-026-09847-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。